FIELD: medicine; cardiology.
SUBSTANCE: invention can be used in the prevention and treatment of functional class III chronic heart failure (CHF) in patients with ventricular tachyarrhythmias and an implanted cardioverter-defibrillator. Patients undergo transthoracic Doppler echocardiography to assess right ventricular systolic pressure, reflecting pulmonary artery systolic pressure, and venous blood is collected to determine the rate of mitochondrial respiration in the medium after adenosine diphosphate has been consumed. Then the probability of developing functional class III CHF is calculated using the original formula. If the prognostic coefficient is more than 0.43, it is predicted that the patient has functional class III CHF.
EFFECT: method makes it possible to increase the effectiveness of CHF therapy in patients with ventricular tachyarrhythmias and an implanted cardioverter-defibrillator, thereby improving the quality of life of patients.
1 cl, 1 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING VENTRICULAR TACHYCARDIA IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND LEFT VENTRICULAR EJECTION FRACTION LESS THAN 35 % | 2021 |
|
RU2770267C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING GASTRIC TACHYCARDIA IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2752362C1 |
METHOD FOR PREDICTION OF POSITIVE RESPONSE TO CARDIO-RESYNCHRONIZING THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF II AND III FUNCTIONAL CLASS | 2022 |
|
RU2786467C1 |
METHOD FOR PHENOTYPING CHRONIC HEART FAILURE BASED ON METABOLOMIC PROFILING | 2024 |
|
RU2841230C1 |
METHOD OF PREDICTING “SUPER RESPONSE” TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH COMPLETE LEFT BUNDLE BRANCH BLOCK AND CHRONIC HEART FAILURE OF VARIOUS ETIOLOGIES | 2023 |
|
RU2813796C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING NONARRHYTHMIC DEATH IN FOUR-YEAR FOLLOW-UP PERIOD IN PATIENTS WITH HEART FAILURE WITH REDUCED LEFT VENTRICULAR FRACTION AND AN IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2820923C1 |
METHOD FOR PREDICTION OF REMOTE UNFAVORABLE OUTCOMES IN PATIENTS WITH HEART FAILURE AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2819279C1 |
METHOD FOR PREDICTING POSITIVE RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH ELECTROCARDIOGRAPHIC CRITERIA OF LEFT BUNDLE BRANCH BLOCK BY STRAUSS | 2024 |
|
RU2830640C1 |
METHOD FOR PREDICTING THE PROGRESSION OF HEART FAILURE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2796311C1 |
METHOD OF PREDICTING RISK OF DEVELOPING ACUTE DECOMPENSATION OF HEART FAILURE IN PATIENTS WITH LOW LEFT VENTRICULAR EJECTION FRACTION AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2809775C1 |
Authors
Dates
2023-11-13—Published
2023-06-27—Filed